TRIM6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.372300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.546620E-01
Normal-vs-Stage2
1.086980E-01
Normal-vs-Stage3
2.196400E-01
Normal-vs-Stage4
4.118200E-01
Stage1-vs-Stage2
3.725800E-01
Stage1-vs-Stage3
9.963000E-01
Stage1-vs-Stage4
7.375000E-01
Stage2-vs-Stage3
4.663000E-01
Stage2-vs-Stage4
8.098000E-01
Stage3-vs-Stage4
7.702800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.689800E-02
Normal-vs-AfricanAmerican
2.870400E-01
Normal-vs-Asian
1.996180E-01
Caucasian-vs-AfricanAmerican
8.954800E-01
Caucasian-vs-Asian
8.460800E-01
AfricanAmerican-vs-Asian
8.269400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.438200E-01
Normal-vs-Female
4.007800E-01
Male-vs-Female
5.436400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.756600E-01
Normal-vs-Age(41-60Yrs)
2.378200E-01
Normal-vs-Age(61-80Yrs)
4.762400E-02
Normal-vs-Age(81-100Yrs)
4.295200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.877600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.392000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.170000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.145600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.068600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.238400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.590560E-01
Normal-vs-Daily Drinker
2.756000E-02
Normal-vs-Weekly Drinker
2.901400E-01
Normal-vs-Occasional Drinker
1.839760E-01
Normal-vs-Social Drinker
2.537200E-01
Non Drinker-vs-Daily Drinker
2.085200E-01
Non Drinker-vs-Weekly Drinker
4.990000E-01
Non Drinker-vs-Occasional Drinker
9.187800E-01
Non Drinker-vs-Social Drinker
7.769400E-01
Daily Drinker-vs-Weekly Drinker
6.011700E-02
Daily Drinker-vs-Occasional Drinker
1.954620E-01
Daily Drinker-vs-Social Drinker
1.626760E-01
Weekly Drinker-vs-Occasional Drinker
5.802000E-01
Weekly Drinker-vs-Social Drinker
7.325600E-01
Occasional Drinker-vs-Social Drinker
8.600000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.915800E-01
Normal-vs-Grade 2
2.055200E-01
Normal-vs-Grade 3
1.652550E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.217800E-03
Grade 1-vs-Grade 3
6.365500E-04
Grade 1-vs-Grade 4
6.915800E-01
Grade 2-vs-Grade 3
7.334200E-02
Grade 2-vs-Grade 4
2.055200E-01
Grade 3-vs-Grade 4
1.652550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.357410E-01
Normal-vs-NonDiabetic
7.432200E-02
Diabetic-vs-NonDiabetic
8.977000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.516800E-01
Normal-vs-NoPancreatitis
7.566100E-02
Pancreatitis-vs-NoPancreatitis
5.010800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.824000E-02
Normal-vs-N1
9.717500E-02
N0-vs-N1
1.280620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.499600E-01
Normal-vs-TP53-NonMutant
1.609450E-01
TP53-Mutant-vs-TP53-NonMutant
8.392400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
